help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Dubal, D. B.
Right arrow Articles by Wise, P. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dubal, D. B.
Right arrow Articles by Wise, P. M.
Endocrinology Vol. 142, No. 1 43-48
Copyright © 2001 by The Endocrine Society

ARTICLES

Neuroprotective Effects of Estradiol in Middle-Aged Female Rats1

Dena B. Dubal and Phyllis M. Wise

Department of Physiology, College of Medicine, University of Kentucky, Lexington, Kentucky 40536-0298

Address all correspondence and requests for reprints to: Phyllis M. Wise, Department of Physiology, College of Medicine, University of Kentucky, Lexington, Kentucky 40536-0298. E-mail: pmwise1{at}pop.uky.edu


   Abstract
Top
 Abstract
Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Estrogen replacement therapy in postmenopausal women ameliorates cognitive dysfunction and decreases the risk and/or severity of neurodegenerative conditions such as Alzheimer’s disease and stroke. Furthermore, estradiol exerts neuroprotective effects in a variety of in vitro and in vivo models of brain injury. We have previously shown that physiological levels of estradiol attenuate ischemic brain injury in young female rats. However, neurodegenerative events occur more frequently in elderly women who are chronically hypoestrogenic. Therefore, we investigated whether aging rats remain responsive to the neuroprotective actions of estradiol. Young (3–4 months) and middle-aged (9–12 months) rats were ovariectomized and treated for 1 week with estradiol before middle cerebral artery occlusion (MCAO). Regional cerebral blood flow was monitored in some animals at the time of injury. Brains were collected 24 h after MCAO and infarct volume was analyzed. Our data demonstrate that in both young and aging rats, low and high physiological doses of estradiol decrease ischemic injury by almost 50%, compared with oil-treated controls. Additionally, our data suggest that estradiol acts in both age groups via blood flow-independent mechanisms, as basal and postinjury blood flow was equivalent between estradiol- and oil-treated young and aging rats. These data demonstrate that replacement with physiological levels of estradiol protects against stroke-related injury in young and aging female rats and strongly suggest that older animals remain responsive to the protective actions of estradiol.


   Introduction
Top
 Abstract
 Introduction
Materials and Methods
 Results
 Discussion
 References
 
IT IS WELL established that estradiol plays a critical reproductive role in the brain during fetal and neonatal development and during adulthood. More recently, it has become increasingly clear that estradiol also plays an important nonreproductive neurotrophic and neuroprotective role (for review see Refs. 2, 3). During development estradiol stimulates neurite outgrowth and arborization of neuritic branches in organotypic cultures (4) and in dispersed neuronal cell cultures (5, 6). In addition, it protects the developing brain against injury in several experimental models (for review see Ref. 3). In the adult, estradiol stimulates the number of functional dendritic spines in the CA1 region of the hippocampus (7, 8) and stimulates synaptogenesis (9). It also protects against brain injury in the adult: estradiol replacement in ovariectomized (OVX) rats significantly decreases ischemic injury (10, 11, 12, 13) and injury induced by other neurotoxic stimuli (14). Moreover, ischemia-induced brain injury is less extensive on proestrus when estradiol is high, than on other days of the estrous cycle (15) and females exhibit less cell death compared with males (11, 16).

Neurodegenerative conditions such as Alzheimer’s disease and cerebrovascular stroke occur more frequently in older postmenopausal than in young women; therefore, it is important to assess whether estrogen continues to exert protective actions in the aging brain. The goals of this study were to determine whether 1) physiological levels of estradiol decrease the extent of brain injury; 2), middle-aged rats remain responsive to these modest levels of estradiol; and 3) the ability of estradiol to protect is mediated by hormone-induced differences in cerebral blood flow.


   Materials and Methods
Top
 Abstract
 Introduction
 Materials and Methods
Results
 Discussion
 References
 
Animals and experimental treatments
Young (3–4 months, 250–300 g BW) and middle-aged (9–12 months, 350–400 g BW) female, Sprague Dawley rats were maintained in a 14-h light, 10-h dark cycle with access to food and water ad libitum. All procedures are in accordance with the NIH Guide and have been approved by the University of Kentucky, Medical Center IACUC Committee. Rats were ovariectomized to eliminate endogenous ovarian estradiol (n = 8–14/experimental group) under Metaphane anesthesia. Immediately after ovariectomy, a SILASTIC brand (Konigsberg Instruments, Pasadena, CA) capsule, containing vehicle (sesame oil, Sigma St. Louis, MO) or 180 µg/ml or 1 mg/ml of 17ß-estradiol (Sigma), was implanted sc into young and middle-aged rats. SILASTIC brand capsules were made by injecting vehicle or estradiol into tubing that was 0.062/0.125 inches inner/outer diameter and that was capped with 5 mm of wooden applicator sticks (Fisher Scientific, Pittsburgh, PA). Capsules were stored in a vial containing oil or the same concentration of estradiol as was in the capsule until they were used. Young rats received a 30-mm capsule (volume 0.070 ml); whereas middle-aged rats received a 40-mm capsule (volume 0.105 ml). The two doses of estradiol replacement (180 µg/ml and 1 mg/ml) delivered through SILASTIC brand capsules produce serum levels of estradiol that are equivalent to basal or proestrous levels observed in the rat estrous cycle, respectively (17). Approximately half (15 of 38) of the young rats were included in a previously published study (12). Both the young and middle-aged rats were collected over the same time interval to ensure that hormone replacement, surgical methods, and analysis of infarct size and cerebral blood flow were consistent in all animals.

In vivo cerebral ischemia
One week after ovariectomy and estradiol or vehicle treatment, rats were anesthetized with a mixture of ketamine/acepromazine (80.0/0.52 mg/kg, ip). Body temperature was monitored with a rectal probe and maintained at 36.5–37.5 C with a heating pad throughout surgery and recovery. Cerebral ischemia was induced via insertion of a 4/0 (young rats) or 4/0 or 3/0 (middle-aged rats) black monofilament suture to occlude the middle cerebral artery (n = 8–14/experimental group). Rats underwent permanent cerebral ischemia using methods described in detail in our previous publication (12). Briefly, the right middle cerebral artery (MCA) was occluded via insertion of a poly-L-lysine coated monofilament suture (Ethicon) from the right external carotid artery, through the right internal carotid artery to the base of the MCA. In a preliminary experiment, insertion of 4/0 and 3/0 sutures was tested to assess whether equivalent occlusion of the MCA in middle-aged rats necessitated the use of the larger diameter suture. The data show that a 3/0 suture (larger diameter) was necessary for successful MCA occlusion in middle-aged rats (Fig. 1Go).



View larger version (16K):
[in this window]
[in a new window]
  		Figure 1. Ischemic injury is equivalent in young and middle-aged rats. A, Cerebral ischemia induced by a 4/0 monofilament suture in young rats (n = 9–10/group) produced ischemic injury that is equivalent to (B) cerebral ischemia induced by a 3/0 monofilament suture in middle-aged rats (n = 4/group). C, The 4/0 monofilament suture produced a significantly smaller infarct in middle-aged females (n = 3/group), compared with young females. Values represent mean ± SE.

 
Histologic preparation
Rats were euthanized using an overdose of ketamine/acepromazine. Brains were collected 24 h after the onset of ischemia and sectioned into 1 mm coronal slices using a brain matrix. As previously described (12), alternate slices were stained in 2% triphenyltetrazolium chloride (TTC) and then fixed in 10% buffered formalin. We analyzed total, cortical, and striatal infarct volumes using coronal sections that span the brain via computer-assisted imaging (NIH version 1.60). The total and regional areas of injury present on each coronal section (bregma points +4.2 mm, +2.2 mm, +0.2 mm, -1.8 mm, -3.8 mm) were clearly demarcated by TTC staining, and measured using NIH Image. Then, for each brain, the areas of injury from the five coronal sections were integrated to determine total, cortical, and striatal infarct volumes (mm3).

Blood flow measurements
One week after ovariectomy and treatment, rats (n = 3/experimental group) were anesthetized with a mixture of ketamine and acepromazine (80.0/0.05 mg/kg ip). Through a craniotomy, a laser Doppler probe (0.8 mm diameter) was positioned over the surface of the right parietal cortex (approximately 5 mm posterior to bregma and 4 mm lateral to the midline). The probe was positioned over an area distant from large pial vessels to obtain low, stable readings representative of cortical perfusion (18). The blood flow measurements were taken from an area that corresponds to the region affected by cerebral ischemia, as ischemic injury spans the brain from approximately 4.2 mm anterior to bregma to 5.8 mm posterior to bregma. Baseline measurements were obtained once a minute for 10 min. Ten minutes after the onset of ischemia, measurements were obtained once a minute for 35 min. Data are expressed as averages over 5 min.

17ß-estradiol RIA
Trunk blood was collected at the time rats were killed, and sera were obtained after centrifugation of the blood. Serum samples were frozen until the time of assay. Sera (n = 7–11/experimental group) were extracted in anhydrous ethyl ether and RIA was conducted for 17ß-estradiol concentrations using a double-antibody commercial kit (ICN Biomedicals, Irvine, CA).

Data analysis
All data are expressed as mean ± SE. Infarct volumes and serum estradiol concentrations were analyzed with one-way ANOVA. Post hoc analyses were carried out with the Newman-Keuls test. Baseline laser Doppler measurements were analyzed using the Student’s t test. Ischemic laser Doppler measurements were analyzed using repeated measures ANOVA. All differences were considered significant at P < 0.05.


   Results
Top
 Abstract
 Introduction
 Materials and Methods
 Results
Discussion
 References
 
In a preliminary experiment, we tested whether a larger diameter suture was required in middle-aged compared with young rats to effectively occlude the MCA. The data show that a 4/0 suture (smaller diameter) produced a significantly smaller infarct in ovariectomized middle-aged rats compared with young rats (Fig. 1Go, A–C). Whereas a 3/0 suture (larger diameter) produced similar infarct volumes in middle-aged as a 4/0 suture produced in young ovariectomized rats. We concluded that the larger diameter suture was necessary for successful MCA occlusion in middle-aged rats (Fig. 1Go, A–C). Therefore, we used a 4/0 suture in young rats and a 3/0 suture in middle-aged rats in all experiments to test whether aging influences the ability of estradiol to protect against ischemic stroke injury.

We found that estradiol dramatically decreased ischemic brain injury in both young and middle-aged female rats, compared with respective oil-treated controls. Figure 2Go is a composite of representative coronal brain sections from oil- and estradiol-treated, young and middle-aged rats following cerebral ischemia. Our data clearly show that both doses of estradiol replacement significantly reduced overall infarct volume as compared with oil-treated controls in both young (Fig. 3AGo) and middle-aged (Fig. 3BGo) rats. The protection afforded by both low and high physiological estradiol pretreatment was identical in both age groups.



View larger version (41K):
[in this window]
[in a new window]
  		Figure 2. Representative brain sections from an oil- and estradiol-treated, young and middle-aged rat after permanent cerebral ischemia. Infarcted tissue is white, whereas live tissue is darkly stained by TTC. In the absence of estradiol, brain injury was extensive in (A) young and (C) middle-aged rats. Physiological estradiol pretreatment (180 µg/ml) reduced the extent of infarct in both (B) young and (D) middle-aged rats. The volume of infarct included significant portions of the cerebral cortex and striatum.

 


View larger version (19K):
[in this window]
[in a new window]
  		Figure 3. Estradiol protects against total ischemic brain injury in young and middle-aged rats. Low and high physiological levels of estradiol decreased total injury in (A) young (Low E: P < 0.01; High E: P < 0.03) and (B) middle-aged (Low E: P < 0.03; High E: P < 0.01) rats. Values represent mean ± SE.

 
To determine whether estradiol’s neuroprotective effects in young and middle-aged rats were region specific, we analyzed treatment effects in the cerebral cortex (Fig. 4Go, A and B) and in the striatum (Fig. 4Go, C and D). Estradiol pretreatment dramatically and equivalently reduced the cortical infarct in both age groups. In contrast, estradiol did not decrease the extent of brain injury in the striatum in young or middle-aged rats.



View larger version (25K):
[in this window]
[in a new window]
  		Figure 4. Effects of estradiol in cerebral ischemia are region specific in young and middle-aged rats. Neuroprotective effects of estradiol were dramatically amplified in the cerebral cortex of (A) young (Low E: P < 0.01; High E: P < 0.01) and (B) middle-aged (Low E: P < 0.05; High E: P < 0.03) rats. No protective effect of estradiol was observed in the striatum of either (C) young (P = 0.41) or (D) middle-aged (P = 0.16) female rats. Values represent mean ± SE.

 
We assessed whether estradiol protects the cerebral cortex of young or middle-aged rats by increasing basal cerebral blood flow, or by attenuating the extent of ischemic flow following MCAO. Table 1Go shows that basal regional cerebral blood flow was not affected by the presence of estradiol. Because baseline blood flow was not affected by hormone treatment or age, we expressed the extent of occlusion as a percentage of baseline. The results show that estradiol did not protect against injury by affecting the extent of decreased blood flow in young (Fig. 5AGo) or middle-aged (Fig. 5BGo) rats.


View this table:
[in this window]
[in a new window]
  		Table 1. Baseline regional cerebral blood flow (rCBF)

 


View larger version (17K):
[in this window]
[in a new window]
  		Figure 5. Ischemic regional cerebral blood flow (rCBF) does not differ between oil- and estradiol-treated, young and middle-aged rats. Ischemia significantly reduced rCBF in oil- and estradiol-treated, (A) young and (B) middle-aged female rats (P < 0.0001). Estradiol treatment did not alter the extent of decrease in regional cortical flow, compared with respective oil-treated controls in young (P = 0.92) or middle-aged (P = 0.94) female rats. Panel A of this figure was modified from Dubal et al. (12 ). Values represent mean ± SE.

 
Figure 6Go shows serum estradiol concentrations produced by insertion of a SILASTIC brand capsule containing either 180 µg/ml or 1 mg/ml concentrations of estradiol in young (Fig. 6AGo) and middle-aged (Fig. 6BGo) rats. The low concentration of estradiol replacement (180 µg/ml) produced equivalent levels of estradiol in both age groups. The higher concentration of estradiol replacement (1 mg/ml) also produced equivalent levels of estradiol in young and middle-aged rats. Low and high physiological estradiol replacement in young and middle-aged rats produced serum 17ß-estradiol levels that are equivalent to basal and proestrous levels circulating in the rat estrous cycle, respectively (17).



View larger version (15K):
[in this window]
[in a new window]
  		Figure 6. Serum 17ß-estradiol levels (pg/ml) are equivalent in young and middle-aged rats that were ovariectomized and estradiol-replaced. Low and high physiological estradiol replacement in (A) young and (B) middle-aged rats produced serum 17ß-estradiol levels that are equivalent to basal, circulating levels and proestrous levels in the rat estrous cycle, respectively. The low range of sensitivity of the assay was determined to be 4 pg/ml. Values represent mean ± SE.

 

   Discussion
Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
References
 
The results of this study clearly establish that estradiol is a potent protective factor in the aging brain. Our study focuses attention on the neuroprotective effects of physiological estradiol in the brain during the middle-aged period of life, when reproductive cycles become irregular and constant estrous becomes more common. We demonstrate three important findings. First, pretreatment with low or high physiological concentrations of estradiol following ovariectomy exerts striking and equivalent neuroprotection against stroke injury induced by permanent MCAO in young and middle-aged rats. Second, estradiol’s effects are region-specific and equivalently amplified in the cerebral cortex of young and middle-aged rats. Third, in parallel to young rats, pretreatment with physiological levels of estradiol appears to protect the brains of middle-aged rats via blood flow-independent mechanisms.

Our observation that physiological levels of estradiol replacement protect the brains of young and middle-aged animals against ischemic injury highlights the vulnerability of the hypoestrogenic brain to neurodegeneration. The data suggest that hypoestrogenic, postmenopausal women may suffer greater consequences from brain injury such as stroke, compared with their counterparts who receive estradiol replacement therapy. Using a paradigm of physiological estradiol replacement in young and middle-aged rats, we specifically investigated effects of physiological levels of estradiol. Our treatment paradigms produced serum levels that are equivalent to basal and proestrous levels of estradiol that circulate in the rat estrous cycle, respectively (17). Our observations clearly demonstrate that in middle-aged female rats, the cerebral cortex remains responsive to the neuroprotective effects of physiological levels of estradiol, compared with young rats. Whether or not older animals remain responsive to estradiol is an important question. However, this question is extremely difficult to approach using the current methods of artery occlusion because arteries become less elastic and, consequently, occlusion using the suture method becomes ineffective (19).

Our finding that estradiol replacement following ovariectomy exerts equivalent neuroprotection between young and middle-aged female rats was unexpected because the ability of estradiol to stimulate a variety of hypothalamic responses required to regulate estrous cyclicity is attenuated in middle-aged rats. This includes attenuation of estradiol’s ability to (1) activate GnRH neurons that leads to LH surges (20, 21, 22) (2), organize diurnal rhythmicity in the hypothalamic neurotransmitter activity (21, 23) or gene expression (24, 25), and (3) stimulate progesterone receptor binding (26). In addition, slightly, but significantly lower, levels of estrogen receptor-{alpha} messenger RNA (mRNA) are expressed in the cerebral cortex of middle-aged compared with young rats (Wilson, M. E., K. L. Rosewell, M. L. Kashon, P. J. Shughrue, I. Merchenthaler, and P. M. Wise, manuscript submitted). For all of these reasons, we had hypothesized that estradiol would be less able to protect the brains of older animals against ischemic brain injury. Interestingly, accumulating evidence from studies in middle-aged peri- and early postmenopausal women, suggests that, in a parallel manner, the hypothalamic/pituitary axis of women becomes less responsive to estradiol (27). Because our data demonstrate that middle-aged rats remain equally responsive to the neuroprotective actions of estradiol compared with young animals, our findings imply that, despite changes in hypothalamic responsiveness, middle-aged women may continue to remain responsive to the nonreproductive, neuroprotective actions of estradiol in the cerebral cortex.

Interestingly, in this model of cerebral ischemia, estradiol’s neuroprotective actions in young and aging female rats are dramatic and amplified in the cerebral cortex, compared with the striatum. The region-specific effect may partially reflect differential blood perfusion to the cortex and striatum following MCA occlusion (28). It is possible that because MCA occlusion blocks blood flow to a greater extent in the striatum compared with the cortex, more necrotic than apoptotic cell death may occur in the severely ischemic, striatal region. Data from our laboratory (29 and our unpublished observations) and others (30, 31) suggest that estradiol protects through mechanisms that attenuate apoptosis. Thus, if cell death in the striatum is predominantly through necrotic mechanisms, we would not expect protection in the striatum. Furthermore, several lines of evidence demonstrate that the cerebral cortex is an important target for estradiol-mediated neuroprotection via estrogen receptor (ER)-mediated mechanisms (29). We discovered that though ER{alpha} mRNA is not normally expressed in the cerebral cortex or the striatum of adult rats (32), cerebral ischemia dramatically and selectively up-regulates ER{alpha}, but not ERß, gene expression in the cortex (29). Furthermore, we investigated the direct roles of estrogen receptor (ER) subtypes, ER{alpha} and ERß, in mediating neuroprotection and found that ER{alpha} plays a pivotal role in the ability of physiological levels of estradiol to protect the cerebral cortex against ischemia (33).

Other studies have examined ischemic brain injury in older animals using similar methods (19, 34). However, because the vasculature becomes less elastic as animals age, it becomes increasingly difficult to occlude the MCA. Indeed, we found that a larger diameter suture was required to occlude the MCA to the same extent in middle-aged rats compared with young rats. Thus, other models of experimental brain injury have been used to assess the effects of neurotoxic stimuli in aging animals (35, 36). For example, older male animals exhibited greater cerebral infarction in response to focal ischemia (37, 38, 39). However, global ischemia has resulted in inconsistent effects in older animals, and this may be related to several variables including strain (15, 40), sex (35, 39, 41), experimental conditions (41) and location of the infarct (39).

A previous study reports effects of stroke in gonadally intact middle-aged female and male rats and found no differences in the extent of ischemic injury (34), concluding that older female rats were less responsive to the protective effects of endogenous estradiol. Several differences between our experimental paradigms may account for the differences in our conclusions. First, intact, reproductively senescent rats, display differing levels of ovarian estradiol, progesterone, and inhibin compared with young rats that depend on the state of reproductive senescence (42, 43). Because progesterone has been shown to exacerbate (Hoffman, Muphy, Le, and Koski, unpublished) and protect (44) against neuronal injury, it is unclear whether the aging animals used in the previous study were as vulnerable to injury because of decreased levels of estradiol or increased levels of progesterone. Second, in the previous study, some gonadally intact middle-aged rats were exposed to exogenous estradiol treatment, in addition to endogenous circulating levels, and this exposure of high levels of estradiol afforded neuroprotection. In contrast to the previous study, all rats in our study were ovariectomized to eliminate endogenous ovarian steroids including estradiol, and then replaced with vehicle or physiological doses of estradiol. Our use of a controlled endocrine paradigm allowed us to specifically test whether physiological levels of estradiol protect the brain against stroke injury.

Estradiol may protect through a variety of cellular and molecular mechanisms. Previous studies have used pharmacological levels of estradiol and demonstrated that these high levels can protect the brain against ischemic injury in transient models of ischemia (10, 45, 46, 47, 48). In some of these studies, pretreatment was not necessary (10, 47, 48). Whereas, in our previous work that uses physiological levels of estradiol replacement in a permanent occlusion model, a pretreatment period was essential to afford protection (12). From these complementary approaches, we hypothesize that when the doses are high and/or when the blood flow is decreased for short periods of time, estradiol may act via nonreceptor mediated mechanisms, such as decreasing free radical generation (49, 50, 51, 52), increasing blood flow (11, 45, 47, 53), decreasing intracellular calcium accumulation (46), inhibiting excitatory amino acid-induced excitotoxicity (51, 52, 54, 55, 56) or rapidly activating second messenger signaling pathways (57, 58, 59, 60). On the other hand, more physiological levels of estradiol replacement are likely to use estrogen receptors that involve changing gene transcription. We have previously found that injury and estradiol alter the expression of several genes, including ER{alpha}, ERß, and members of the bcl-2 (29) and immediate early gene family (61). Our most recent findings demonstrate a functional role for ER{alpha} as the critical estrogen receptor subtype that mediates neuroprotective effects of physiological levels of estradiol in stroke injury (33).

In summary, our results clearly establish that estradiol plays a neuroprotective role in the injured brain in both young and middle-aged rats. The data strongly imply that older women may also benefit from the protective effects of estrogen replacement therapy that uses relatively low concentrations of hormone.


   Footnotes
 
1 Supported in part by NIH Grant AG-02224 (to P.M.W.), NIH Predoctoral fellowship T32-AG-00242 (to D.B.D.), Merck/American Federation for Aging Research Scholarship (to D.B.D.), and Glenn Foundation/American Federation for Aging Research Scholarship (to D.B.D.). Some of these data were presented in a minireview that summarized a symposium contribution by PMW (1 ). Back

Received July 27, 2000.


   References
Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 

  1. Wise PM, Dubal DB 2000 Estradiol protects against ischemic brain injury in middle-aged rats. Biol Reprod 63:982–985[Abstract/Free Full Text]
  2. McEwen BS, Alves SE 1999 Estrogen actions in the central nervous system. Endocr Rev 20:279–307[Abstract/Free Full Text]
  3. Wise PM, Dubal DB, Wilson ME, Rau SW, Liu Y Estrogens: trophic and protective factors in the adult brain. Front Neuroendocrinol, in press
  4. Toran-Allerand CD 1991 Organotypic culture of the developing cerebral cortex and hypothalamus relevance to sexual differentiation. Psychoneuroendocrinology 16:7–24[CrossRef][Medline]
  5. Murphy DD, Segal M 1996 Regulation of dendritic spine density in cultured rat hippocampal neurons by steroid hormones. J Neurosci 16:4059–4068[Abstract/Free Full Text]
  6. Brinton RD, Tran J, Proffitt P, Montoya M 1997 17ß-estradiol enhances the outgrowth and survival of neocortical neurons in culture. Neurochem Res 22:1339–1351[CrossRef][Medline]
  7. Gould E, Woolley CS, Frankfurt M, McEwen BS 1990 Gonadal steroids regulate dendritic spine density in hippocampal pyramidal cells in adulthood. J Neurosci 10:1286–1291[Abstract]
  8. Woolley CS, McEwen BS 1993 Roles of estradiol and progesterone in regulation of hippocampal dendritic spine density during the estrous cycle in the rat. J Comp Neurol 336:293–306[CrossRef][Medline]
  9. Woolley CS, Wenzel HJ, Schwartzkroin PA 1996 Estradiol increases the frequency of multiple synapse boutons in the hippocampal CA1 region of the adult female rat. J Comp Neurol 373:108–117[CrossRef][Medline]
  10. Simpkins JW, Rajakumar G, Zhang Y-Q, Simpkins CE, Greenwald D, Yu CJ, Bodor N, Day AL 1997 Estrogens may reduce mortality and ischemic damage caused by middle cerebral artery occlusion in the female rat. J Neurosurg 87:724–730[Medline]
  11. Alkayed NJ, Harukuni I, Kimes AS, London ED, Traystman RJ, Hurn PD 1998 Gender-linked brain injury in experimental stroke. Stroke 29:159–166[Abstract/Free Full Text]
  12. Dubal DB, Kashon ML, Pettigrew LC, Ren JM, Finklestein SP, Rau SW, Wise PM 1998 Estradiol protects against ischemic injury. J Cereb Blood Flow Metab 18:1253–1258[CrossRef][Medline]
  13. Zhang Y-Q, Shi J, Rajakumar G, Day AL, Simpkins JW 1998 Effects of gender and estradiol treatment on focal brain ischemia. Brain Res 784:321–324[CrossRef][Medline]
  14. Garcia-Estrada J, DelRio JA, Luquin S, Soriano E, Garcia-Segura LM 1993 Gonadal hormones down-regulate reactive gliosis and astrocyte proliferation after a penetrating brain injury. Brain Res 628:271–278[CrossRef][Medline]
  15. Carswell HV, Dominiczak AF, Macrae IM 2000 Estrogen status affects sensitivity to focal cerebral ischemia in stroke-prone spontaneously hypertensive rats. Am J Physiol Heart Circ Physiol 278:H290–H294
  16. Hall ED, Pazara KE, Linseman KL 1991 Sex differences in postischemic neuronal necrosis in gerbils. J Cereb Blood Flow Metab 11:292–298[Medline]
  17. Smith MS, Freeman ME, Neill JD 1975 The control of progesterone secretion during the estrous cycle and early pseudopregnancy in the rat: prolactin, gonadotropin and steroid levels associated with rescue of the corpus luteum of pseudopregnancy. Endocrinology 96:219–226[Abstract/Free Full Text]
  18. Cholet N, Seylaz J, Lacombe P, Bonvento G 1997 Local uncoupling of the cerebrovascular and metabolic responses to somatosensory stimulation after neuronal nitric oxide synthhase inhibition. J Cereb Blood Flow Metab 17:1191–1191[CrossRef][Medline]
  19. Wang LJC, Futrell N, Wang DZ, Chen FJ, Zhai Qh, Schultz LR 1995 A reproducible model of middle cerebral infarcts, compatible with long-term survival, in aged rats. Stroke 26:2087–2090[Abstract/Free Full Text]
  20. Lloyd JM, Hoffman GE, Wise PM 1994 Decline in immediate early gene expression in gonadotropin-releasing hormone neurons during proestrus in regularly cycling, middle-aged rats. Endocrinology 134:1800–1805[Abstract/Free Full Text]
  21. Wise PM 1982 Norepinephrine and dopamine activity in microdissected brain areas of the middle-aged and young rat on proestrus. Biol Reprod 27:562–574[CrossRef][Medline]
  22. Wise PM 1984 Estradiol-induced daily luteinizing hormone and prolactin surges in young and middle-aged rats: correlations with age-related changes in pituitary responsiveness and catecholamine turnover rates in microdissected brain areas. Endocrinology 115:801–809[Abstract/Free Full Text]
  23. Cohen IR, Wise PM 1988 Age-related changes in the diurnal rhythm of serotonin turnover in microdissected brain areas of estradiol-treated ovariectomized rats. Endocrinology 122:2626–2633[Abstract/Free Full Text]
  24. Krajnak K, Kashon ML, Rosewell KL, Wise PM 1998 Aging alters the rhythmic expression of vasoactive intestinal polypeptide mRNA, but not arginine vasopressin mRNA in the suprachiasmatic nuclei of female rats. J Neurosci 18:4767–4774[Abstract/Free Full Text]
  25. Weiland NG, Scarbrough K, Wise PM 1992 Aging abolishes the estradiol-induced suppression and diurnal rhythm of proopiomelanocortin gene expression in the arcuate nucleus. Endocrinology 131:2959–2964[Abstract/Free Full Text]
  26. Wise PM, McEwen BS, Parsons B, Rainbow TC 1984 Age-related changes in cytoplasmic estradiol receptor concentrations in microdissected brain nuclei: correlations with changes in steroid-induced sexual behavior. Brain Res 321:119–126[CrossRef][Medline]
  27. Park SJ, Goldsmith LT, Reinert A, Skurnick JH, Castracane VD, Weiss G Perimenopausal women are deficient in an estrogen positive feedback on LH secretion mechanism. Program of the 82nd Annual Meeting of The Endocrine Society, Toronto, Canada, 2000, p 69, (Abstract 248)
  28. Tsuchidate R, He Q-P, Smith M-L, Siesjo BK 1997 Regional cerebral blood flow during and after 2 hours of middle cerebral artery occlusion in the rat. J Cereb Blood Flow Metab 17:1066–1073[CrossRef][Medline]
  29. Dubal DB, Shughrue PJ, Wilson ME, Merchenthaler I, Wise PM 1999 Estradiol modulates Bcl-2 in cerebral ischemia: a potential role for estrogen receptors. J Neurosci 19:6385–6393[Abstract/Free Full Text]
  30. Garcia-Segura LM, Cardona-Gomez P, Naftolin F, Chowen JA 1998 Estradiol upregulates Bcl-2 expression in adult brain neurons. Neuroreport 9:593–597[Medline]
  31. Singer CA, Rogers KL, Dorsa DM 1998 Modulation of Bcl-2 expression: a potential component of estrogen protection in NT2 neurons. Neuroreport 9:2565–2568[Medline]
  32. Shughrue PJ, Lane MV, Merchenthaler I 1997 Comparative distribution of estrogen receptor-{alpha} and -ß mRNA in the rat central nervous system. J Comp Neurol 388:507–525[CrossRef][Medline]
  33. Dubal DB, Zhu H, Yu J, Rau SW, Shughrue PJ, Merchenthaler I, Kindy MS, Wise PM Estrogen receptor alpha is critical in estradiol-mediated neuroprotection against stroke injury: insights from ER-{alpha} knockout mice. Society for Neuroscience, 2000, p 779, (Abstract 288.4)
  34. Alkayed JJ, Murphy SJ, Traystman RJ, Hurn PD 2000 Neuroprotective effects of female gonadal steroids in reproductively senescent female rats. Stroke 31:161–168[Abstract/Free Full Text]
  35. Yao H, Sadoshima S, Ooboshi H, Sato Y, Uchimura H, Fujishima M 1991 Age-related vulnerability to cerebral ischemia in spontaneously hypertensive rats. Stroke 22:1414–1418[Abstract/Free Full Text]
  36. Auer RN 1996 Effect of age and sex on N-methyl-D-aspartate antagonist-induced neuronal necrosis in rats. Stroke 27:743–746[Abstract/Free Full Text]
  37. Futrell N, Garcia JH, Peterson E, Millikan C 1991 Embolic stroke in aged rats. Stroke 22:1582–1591[Abstract/Free Full Text]
  38. Davis M, Mendelow AD, Perry RH, Chambers IR, James OF 1995 Experimental stroke and neuroprotection in the aging rat brain. Stroke 26:1072–1078[Abstract/Free Full Text]
  39. Sutherland GR, Six GA, Auer RN 1996 Effect of age in rodent models of focal and forebrain ischemia. Stroke 27:1663–1667[Abstract/Free Full Text]
  40. Canese R, Fortuna S, Lorenzini P, Podo F, Michalek H 1998 Transient global brain ischemia in young and aged rats: differences in severity and progression, but not localisation, of lesions evaluated by magnetic resonance imaging. MAGMA 7:28–34
  41. Baughman VL, Hoffman WE, Thomas C, Miletich DJ, Albrecht RF 1988 Neurologic outcome in aged rats after incomplete cerebral ischemia. Anesth Analg 67:677–682[Abstract/Free Full Text]
  42. DePaolo LV 1987 Age-associated increases in serum follicle-stimulating hormone levels on estrus are accompanied by a reduction in the ovarian secretion of inhibin. Exp Aging Res 13:3–7[Medline]
  43. Lu KH, Hopper BR, Vargo TM, Yen SSC 1979 Chronological changes in sex steroid, gonadotropin and prolactin secretion in aging female rats displaying different reproductive states. Biol Reprod 21:193–203[Abstract]
  44. Roof RL, Duvdevani R, Stein DG 1991 Gender influences outcome of brain injury: progesterone plays a protective role. Brain Res 607:333–336
  45. Hurn PD, Littleton-Kearney MT, Kirsch JR, Dharmarajan AM, Traystman RJ 1995 Postischemic cerebral blood flow recovery in the female: effect of 17ß-estradiol. J Cereb Blood Flow Metab 15:666–672[Medline]
  46. Chen J, Adachi N, Liu K, Arai T 1998 The effects of 17ß-estradiol on ischemia-induced neuronal damage in the gerbil hippocampus. Neuroscience 87:817–822[CrossRef][Medline]
  47. Toung TJK Traystman RJ Hurn PD 1998 Estrogen-mediated neuroprotection after experimental stroke in male rats. Stroke 29:1666–1670[Abstract/Free Full Text]
  48. Yang S-H, Shi J, Day AL, Simpkins JW 2000 Estradiol exerts neuroprotective effects when administered after ischemic insult. Stroke 31:745–750[Abstract/Free Full Text]
  49. Kume-Kick J, Rice ME 1998 Estrogen-dependent modulation of rat brain ascorbate levels and ischemia-induced ascorbate loss. Brain Res 803:105–113[CrossRef][Medline]
  50. Hall ED, Braughler JM 1993 Free radicals in CNS injury. In: Waxman SG (ed) Molecular and Cellular Approaches to the Treatment of Neurological Disease. New York: Raven Press, pp 81–105
  51. Behl C, Skutella T, Lezoualc’h F, Post A, Widmann M, Newton CJ, Holsboer F 1997 Neuroprotection against oxidative stress by estrogens: structure-activity relationship. Mol Pharmacol 51:535–541[Abstract/Free Full Text]
  52. Behl C, Widmann M, Trapp T, Holsboer F 1998 17-ß Estradiol protects neurons from oxidative stress-induced cell death in vitro. Biochem Biophys Res Commun 216:473–482
  53. Pelligrino DA, Santizo R, Baughman VL, Wang Q 1998 Cerebral vasodilating capacity during forebrain ischemia: effects of chronic estrogen depletion and repletion and the role of neuronal nitric oxide synthetase. Neuroreport 9:3285–3291[Medline]
  54. Goodman Y, Bruce AJ, Cheng B, Mattson MP 1996 Estrogens attenuate and corticosterone exacerbates excitotoxicity, oxidative injury, and amyloid ß-peptide toxicity in hippocampal neurons. J Neurochem 66:1836–1844[Medline]
  55. Keller JN, Germeyer A, Begley JG, Mattson MP 1997 17ß-estradiol attenuates oxidative impairment of synaptic Na+/K+-ATP-ase activity, glucose transport, and glutamate transport induced by amyloid ß-peptide and iron. J Neurosci Res 50:522–530[CrossRef][Medline]
  56. Weaver Jr CE, Park-Chung M, Gibbs TT, Farb DH 1997 17-ß-estradiol protects against NMDA-induced excitotoxicity by direct inhibition of NMDA receptors. Brain Res 761:338–341[CrossRef][Medline]
  57. Zhou Y, Watters JJ, Dorsa DM 1996 Estrogen rapidly induces the phosphorylation of the cAMP response element binding protein in rat brain. Endocrinology 137:2163–2166[Abstract]
  58. Watters JJ, Campbell JS, Cunningham MJ, Krebs EG, Dorsa DM 1997 Rapid membrane effects of steroids in neuroblastoma cells: effects of estrogen on mitogen activated protein kinase signalling cascade and c-fos immediate early gene transcription. Endocrinology 139:4030–4033
  59. Singer CA, Figueroa-Masot CD, Batchelor RH, Dorsa DM 1999 The mitogen-activated protein kinase pathway mediates estrogen neuroprotection after glutamate toxicity in primary cortical neurons. J Neurosci 19:2455–2463[Abstract/Free Full Text]
  60. Singh M, Setalo Jr G, Guan X, Warren M, Toran-Allerand CD 1999 Estrogen-induced activation of mitogen-activated protein kinase in cerebral cortical explants: convergence of estrogen and neurotrophin signaling pathways. J Neurosci 19:1179–1188[Abstract/Free Full Text]
  61. Rau SW, Dubal D, Wise PM Immediate early gene regulation by estradiol in ischemic injury. Program of the 30th Annual Meeting of the Society for Neuroscience, New Orleans, LA, 2000, p 778, (Abstract 288.1)



This article has been cited by other articles:


Home page
 J. Neurosci.Home page
L. D. Brewer, A. L. S. Dowling, M. A. Curran-Rauhut, P. W. Landfield, N. M. Porter, and E. M. Blalock
Estradiol Reverses a Calcium-Related Biomarker of Brain Aging in Female Rats
J. Neurosci., May 13, 2009; 29(19): 6058 - 6067.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
S. Deurveilher, E. M. Cumyn, T. Peers, B. Rusak, and K. Semba
Estradiol replacement enhances sleep deprivation-induced c-Fos immunoreactivity in forebrain arousal regions of ovariectomized rats
Am J Physiol Regulatory Integrative Comp Physiol, October 1, 2008; 295(4): R1328 - R1340.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
W. Huang, M. Acosta-Martinez, and J. E. Levine
Ovarian Steroids Stimulate Adenosine Triphosphate-Sensitive Potassium (KATP) Channel Subunit Gene Expression and Confer Responsiveness of the Gonadotropin-Releasing Hormone Pulse Generator to KATP Channel Modulation
Endocrinology, May 1, 2008; 149(5): 2423 - 2432.
[Abstract] [Full Text] [PDF]

Home page
 StrokeHome page
P. Cordeau Jr, M. Lalancette-Hebert, Y. C. Weng, and J. Kriz
Live Imaging of Neuroinflammation Reveals Sex and Estrogen Effects on Astrocyte Response to Ischemic Injury
Stroke, March 1, 2008; 39(3): 935 - 942.
[Abstract] [Full Text] [PDF]

Home page
 Endocr. Rev.Home page
M. Schumacher, R. Guennoun, A. Ghoumari, C. Massaad, F. Robert, M. El-Etr, Y. Akwa, K. Rajkowski, and E.-E. Baulieu
Novel Perspectives for Progesterone in Hormone Replacement Therapy, with Special Reference to the Nervous System
Endocr. Rev., June 1, 2007; 28(4): 387 - 439.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
D. B. Dubal, S. W. Rau, P. J. Shughrue, H. Zhu, J. Yu, A. B. Cashion, S. Suzuki, L. M. Gerhold, M. B. Bottner, S. B. Dubal, et al.
Differential Modulation of Estrogen Receptors (ERs) in Ischemic Brain Injury: A Role for ER{alpha} in Estradiol-Mediated Protection against Delayed Cell Death
Endocrinology, June 1, 2006; 147(6): 3076 - 3084.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
G. D. Hilton, L. L. Bambrick, S. M. Thompson, and M. M. McCarthy
Estradiol Modulation of Kainic Acid-Induced Calcium Elevation in Neonatal Hippocampal Neurons
Endocrinology, March 1, 2006; 147(3): 1246 - 1255.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
D. A. Schreihofer, K. D. Do, and A. M. Schreihofer
High-soy diet decreases infarct size after permanent middle cerebral artery occlusion in female rats
Am J Physiol Regulatory Integrative Comp Physiol, July 1, 2005; 289(1): R103 - R108.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
K. M. Dhandapani, F. M. Wade, V. B. Mahesh, and D. W. Brann
Astrocyte-Derived Transforming Growth Factor-{beta} Mediates the Neuroprotective Effects of 17{beta}-Estradiol: Involvement of Nonclassical Genomic Signaling Pathways
Endocrinology, June 1, 2005; 146(6): 2749 - 2759.
[Abstract] [Full Text] [PDF]

Home page
 Endocr. Rev.Home page
R. G. Smith, L. Betancourt, and Y. Sun
Molecular Endocrinology and Physiology of the Aging Central Nervous System
Endocr. Rev., April 1, 2005; 26(2): 203 - 250.
[Abstract] [Full Text] [PDF]

Home page
 Exp. Biol. Med.Home page
T. R. Chakraborty and A. C. Gore
Aging-Related Changes in Ovarian Hormones, Their Receptors, and Neuroendocrine Function
Experimental Biology and Medicine, November 1, 2004; 229(10): 977 - 987.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurosci.Home page
S. W. Rau, D. B. Dubal, M. Bottner, L. M. Gerhold, and P. M. Wise
Estradiol Attenuates Programmed Cell Death after Stroke-Like Injury
J. Neurosci., December 10, 2003; 23(36): 11420 - 11426.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurosci.Home page
S. W. Rau, D. B. Dubal, M. Bottner, and P. M. Wise
Estradiol Differentially Regulates c-Fos after Focal Cerebral Ischemia
J. Neurosci., November 19, 2003; 23(33): 10487 - 10494.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurosci.Home page
J. K. Wong, H. H. Le, A. Zsarnovszky, and S. M. Belcher
Estrogens and ICI182,780 (Faslodex) Modulate Mitosis and Cell Death in Immature Cerebellar Neurons via Rapid Activation of p44/p42 Mitogen-Activated Protein Kinase
J. Neurosci., June 15, 2003; 23(12): 4984 - 4995.
[Abstract] [Full Text] [PDF]

Home page
 Biol. Reprod.Home page
K. M. Dhandapani and D. W. Brann
Protective Effects of Estrogen and Selective Estrogen Receptor Modulators in the Brain
Biol Reprod, November 1, 2002; 67(5): 1379 - 1385.
[Abstract] [Full Text] [PDF]

Home page
 StrokeHome page
R. Liu, S.-H. Yang, E. Perez, K. D. Yi, S. S. Wu, K. Eberst, L. Prokai, K. Prokai-Tatrai, Z. Y. Cai, D. F. Covey, et al.
Neuroprotective Effects of a Novel Non-Receptor-Binding Estrogen Analogue: In Vitro and In Vivo Analysis
Stroke, October 1, 2002; 33(10): 2485 - 2491.
[Abstract] [Full Text] [PDF]

Home page
 Arch Intern MedHome page
H. M. Fillit
The Role of Hormone Replacement Therapy in the Prevention of Alzheimer Disease
Arch Intern Med, September 23, 2002; 162(17): 1934 - 1942.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurosci.Home page
T. Jover, H. Tanaka, A. Calderone, K. Oguro, M. V. L. Bennett, A. M. Etgen, and R. S. Zukin
Estrogen Protects against Global Ischemia-Induced Neuronal Death and Prevents Activation of Apoptotic Signaling Cascades in the Hippocampal CA1
J. Neurosci., March 15, 2002; 22(6): 2115 - 2124.
[Abstract] [Full Text] [PDF]

Home page
 Recent Prog Horm ResHome page
P. M. Wise, M. J. Smith, D. B. Dubal, M. E. Wilson, S. W. Rau, A. B. Cashion, M. Bottner, and K. L. Rosewell
Neuroendocrine Modulation and Repercussions of Female Reproductive Aging
Recent Prog. Horm. Res., January 1, 2002; 57(1): 235 - 256.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
D. B. Dubal, H. Zhu, J. Yu, S. W. Rau, P. J. Shughrue, I. Merchenthaler, M. S. Kindy, and P. M. Wise
Estrogen receptor alpha , not beta , is a critical link in estradiol-mediated protection against brain injury
PNAS, February 1, 2001; (2001) 41483198.
[Abstract] [Full Text]

Home page
 Proc. Natl. Acad. Sci. USAHome page
D. B. Dubal, H. Zhu, J. Yu, S. W. Rau, P. J. Shughrue, I. Merchenthaler, M. S. Kindy, and P. M. Wise
Estrogen receptor alpha , not beta , is a critical link in estradiol-mediated protection against brain injury
PNAS, February 13, 2001; 98(4): 1952 - 1957.
[Abstract] [Full Text] [PDF]

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Dubal, D. B.
Right arrow Articles by Wise, P. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dubal, D. B.
Right arrow Articles by Wise, P. M.

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals